{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:15:44Z","timestamp":1791299744246,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.7759\/cureus.83304","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:10:01Z","timestamp":1746115801000},"source":"Crossref","is-referenced-by-count":3,"title":["The Use of Bone Marrow Transplantation (BMT) or Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients Diagnosed With Ataxia-Telangiectasia: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Saad Ali M","family":"Alqarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujaine M","family":"Al Murayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan Y","family":"Mushari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura H","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt C","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016, 11:159. 10.1186\/s13023-016-0543-7","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.07.001","article-title":"Allogeneic stem cell transplantation after Fanconi anemia conditioning in children with ataxia-telangiectasia results in stable T cell engraftment and lack of infections despite mixed chimerism","volume":"24","author":"Ussowicz M","year":"2018","unstructured":"Ussowicz M, Wawrzyniak-Dzier\u017cek E, Mielcarek-Siedziuk M, et al.. Allogeneic stem cell transplantation after Fanconi anemia conditioning in children with ataxia-telangiectasia results in stable T cell engraftment and lack of infections despite mixed chimerism. Biol Blood Marrow Transplant. 2018, 24:2245-9. 10.1016\/j.bbmt.2018.07.001","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies","volume":"33","author":"Suarez F","year":"2015","unstructured":"Suarez F, Mahlaoui N, Canioni D, et al.. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015, 33:202-8. 10.1200\/JCO.2014.56.5101","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186041","article-title":"Ataxia telangiectasia arising as immunodeficiency: The intriguing differential diagnosis","volume":"12","author":"Cavone F","year":"2023","unstructured":"Cavone F, Cappelli S, Bonuccelli A, et al.. Ataxia telangiectasia arising as immunodeficiency: The intriguing differential diagnosis. J Clin Med. 2023, 12:41. 10.3390\/jcm12186041","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0373-z","article-title":"Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study","volume":"10","author":"Pommerening H","year":"2015","unstructured":"Pommerening H, van Dullemen S, Kieslich M, Schubert R, Zielen S, Voss S. Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study. Orphanet J Rare Dis. 2015, 10:155. 10.1186\/s13023-015-0373-z","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2024.101169","article-title":"Ataxia telangiectasia","volume":"52","author":"Collyer J","year":"2024","unstructured":"Collyer J, Rajan DS. Ataxia telangiectasia. Semin Pediatr Neurol. 2024, 52:101169. 10.1016\/j.spen.2024.101169","journal-title":"Semin Pediatr Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives","volume":"7","author":"Castagnoli R","year":"2019","unstructured":"Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD. Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Front Pediatr. 2019, 7:295. 10.3389\/fped.2019.00295","journal-title":"Front Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113207","article-title":"Bone marrow transplantation as therapy for ataxia-telangiectasia: a systematic review","volume":"12","author":"Sabino Pinho de Oliveira B","year":"2020","unstructured":"Sabino Pinho de Oliveira B, Putti S, Naro F, Pellegrini M. Bone marrow transplantation as therapy for ataxia-telangiectasia: a systematic review. Cancers (Basel). 2020, 12:7. 10.3390\/cancers12113207","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.240309","article-title":"Translational and clinical advances in acute graft-versus-host disease","volume":"105","author":"Gooptu M","year":"2020","unstructured":"Gooptu M, Koreth J. Translational and clinical advances in acute graft-versus-host disease. Haematologica. 2020, 105:2550-60. 10.3324\/haematol.2019.240309","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","article-title":"Clinical presentation of ataxia-telangiectasia","volume":"22","author":"Alyasin S","year":"2019","unstructured":"Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Nemati H. Clinical presentation of ataxia-telangiectasia. Arch Iran Med. 2019, 22:682-6.","journal-title":"Arch Iran Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2016.05.012","article-title":"Treatment of acute leukemia in children with ataxia telangiectasia (A-T)","volume":"59","author":"Schoenaker MH","year":"2016","unstructured":"Schoenaker MH, Suarez F, Szczepanski T, Mahlaoui N, Loeffen JL. Treatment of acute leukemia in children with ataxia telangiectasia (A-T). Eur J Med Genet. 2016, 59:641-6. 10.1016\/j.ejmg.2016.05.012","journal-title":"Eur J Med Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21911\/aai.006","article-title":"Evaluation of clinical and laboratory features of patients with ataxia-telangiectasia","volume":"21","author":"Kilic M","year":"2023","unstructured":"Kilic M, Gunbey O, Taskin E, Dag B, Kucuk E, Gunbey FB, Sen A. Evaluation of clinical and laboratory features of patients with ataxia-telangiectasia. Asthma Allergy Immunol. 2023, 21:3-10. 10.21911\/aai.006","journal-title":"Asthma Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.02.036","article-title":"Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders","volume":"141","author":"Slack J","year":"2018","unstructured":"Slack J, Albert MH, Balashov D, et al.. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. J Allergy Clin Immunol. 2018, 141:322-28.e10. 10.1016\/j.jaci.2017.02.036","journal-title":"J Allergy Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP2JBDEELPA7HT","article-title":"Evaluation of monoclonal and oligoclonal gammopathies in a pediatric population in a major urban center","volume":"141","author":"Karafin MS","year":"2014","unstructured":"Karafin MS, Humphrey RL, Detrick B. Evaluation of monoclonal and oligoclonal gammopathies in a pediatric population in a major urban center. Am J Clin Pathol. 2014, 141:482-7. 10.1309\/AJCP2JBDEELPA7HT","journal-title":"Am J Clin Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-310373","article-title":"Growth and nutrition in children with ataxia telangiectasia","volume":"101","author":"Stewart E","year":"2016","unstructured":"Stewart E, Prayle AP, Tooke A, Pasalodos S, Suri M, Bush A, Bhatt JM. Growth and nutrition in children with ataxia telangiectasia. Arch Dis Child. 2016, 101:1137-41. 10.1136\/archdischild-2015-310373","journal-title":"Arch Dis Child"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01495","article-title":"Cancer in children with Fanconi anemia and ataxia-telangiectasia-a nationwide register-based cohort study in Germany","volume":"40","author":"Dutzmann CM","year":"2022","unstructured":"Dutzmann CM, Spix C, Popp I, et al.. Cancer in children with Fanconi anemia and ataxia-telangiectasia-a nationwide register-based cohort study in Germany. J Clin Oncol. 2022, 40:32-9. 10.1200\/JCO.21.01495","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13424","article-title":"Ataxia-telangiectasia: recommendations for multidisciplinary treatment","volume":"59","author":"van Os NJ","year":"2017","unstructured":"van Os NJ, Haaxma CA, van der Flier M, et al.. Ataxia-telangiectasia: recommendations for multidisciplinary treatment. Dev Med Child Neurol. 2017, 59:680-9. 10.1111\/dmcn.13424","journal-title":"Dev Med Child Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362800-the-use-of-bone-marrow-transplantation-bmt-or-hematopoietic-stem-cell-transplantation-hsct-in-pediatric-patients-diagnosed-with-ataxia-telangiectasia-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:10:02Z","timestamp":1746115802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362800-the-use-of-bone-marrow-transplantation-bmt-or-hematopoietic-stem-cell-transplantation-hsct-in-pediatric-patients-diagnosed-with-ataxia-telangiectasia-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.83304","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}